PubRank

Robyn L Stanfield

Author PubWeight™ 90.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Structure of a V3-containing HIV-1 gp120 core. Science 2005 7.69
2 How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006 7.57
3 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 2003 6.68
4 Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 2013 5.53
5 A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 2011 5.44
6 Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4. Science 2007 4.35
7 Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41. Immunity 2005 4.26
8 Antibody vs. HIV in a clash of evolutionary titans. Proc Natl Acad Sci U S A 2005 3.57
9 Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 2012 3.53
10 Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 2013 3.11
11 Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor. J Virol 2004 2.80
12 Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1. Proc Natl Acad Sci U S A 2010 2.77
13 Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans. PLoS Pathog 2013 2.66
14 Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci U S A 2005 2.50
15 Contrasting IgG structures reveal extreme asymmetry and flexibility. J Mol Biol 2002 2.10
16 Hepatitis C virus E2 envelope glycoprotein core structure. Science 2013 2.06
17 The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J Virol 2004 2.02
18 Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1. Proc Natl Acad Sci U S A 2012 1.74
19 A conformational switch in human immunodeficiency virus gp41 revealed by the structures of overlapping epitopes recognized by neutralizing antibodies. J Virol 2009 1.63
20 Structure of the GLD-1 homodimerization domain: insights into STAR protein-mediated translational regulation. Structure 2010 1.62
21 Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. J Mol Biol 2007 1.42
22 Very few substitutions in a germ line antibody are required to initiate significant domain exchange. J Virol 2010 1.41
23 Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign. Proc Natl Acad Sci U S A 2014 1.34
24 Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc Natl Acad Sci U S A 2012 1.18
25 Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33. J Virol 2012 1.18
26 Malachite green mediates homodimerization of antibody VL domains to form a fluorescent ternary complex with singular symmetric interfaces. J Mol Biol 2013 1.08
27 A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3. J Biol Chem 2004 1.08
28 An αß T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 1996. 274: 209-219. J Immunol 2010 1.07
29 Structure determination of an anti-HIV-1 Fab 447-52D-peptide complex from an epitaxially twinned data set. Acta Crystallogr D Biol Crystallogr 2008 1.03
30 Antibody modeling assessment II. Structures and models. Proteins 2014 0.99
31 A variable light domain fluorogen activating protein homodimerizes to activate dimethylindole red. Biochemistry 2012 0.95
32 First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate. Proc Natl Acad Sci U S A 2006 0.92
33 Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development. Immunogenetics 2002 0.92
34 MHC restriction: slip-sliding away. Nat Immunol 2005 0.86
35 A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120. FASEB J 2008 0.86
36 Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design. Adv Exp Med Biol 2003 0.81
37 Adaptive mutations alter antibody structure and dynamics during affinity maturation. Biochemistry 2015 0.81
38 Specific recognition of a DNA immunogen by its elicited antibody. J Mol Biol 2007 0.78
39 Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design. PLoS Pathog 2016 0.78
40 Antibody Structure. Microbiol Spectr 2014 0.75